PsychoGenics is using AI to rapidly screen for psychotic treatments

PsychoGenics has developed a drug-discovery application powered by AI technology. Its first objective is to find a formula capable of effectively treating schizophrenia.

Thred Media
3 min readAug 31, 2023

--

The development of new drugs is an impressive science, but most cases begin with an educated hunch and a lot of guess work.

Around only 1 in 1,000 candidates for new treatments ever make it to clinical trials for human testing, and just 1 in 10 of these end up on the market.

Many of the drugs available in pharmacies internationally will have likely taken some 10 years to develop and cost millions of dollars. This may not be the case for much longer regarding psychotic treatments, however, as researchers turn to the increasingly familiar tool of AI.

PsychoGenics, a preclinical organisation hailing from New Jersey, is keen to carry forth the new frontier of medical serendipity using its eponymous platform as well as something called ‘SmartCube’.

The earliest stage of screening is carried out by the former tool, which searches through mounds of complex data on molecular patterns that could otherwise take researchers an entire lifetime.

--

--